Found: 72
Select item for more details and to access through your institution.
Immunogenicity after heterologous third dose COVID‐19 vaccination in a heart transplant recipient.
- Published in:
- Clinical Transplantation, 2022, v. 36, n. 4, p. 1, doi. 10.1111/ctr.14605
- By:
- Publication type:
- Article
Identification of immunodominant T cell epitopes induced by natural Zika virus infection.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1247876
- By:
- Publication type:
- Article
The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1093242
- By:
- Publication type:
- Article
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abi8961
- By:
- Publication type:
- Article
The Effect of Anticoagulants, Temperature, and Time on the Human Plasma Metabolome and Lipidome from Healthy Donors as Determined by Liquid Chromatography-Mass Spectrometry.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 5, p. 200, doi. 10.3390/biom9050200
- By:
- Publication type:
- Article
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
An Inactivated Virus Candidate Vaccine to Prevent COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A New Vaccine for Chikungunya Virus.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0273526
- By:
- Publication type:
- Article
Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor-α Inhibitors.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 6, p. 924, doi. 10.1086/605498
- By:
- Publication type:
- Article
A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8[sup+] Cytotoxic T Lymphocyte Responses in Seronegative Volunteers.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2, doi. 10.1086/314895
- By:
- Publication type:
- Article
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 2, p. 310, doi. 10.1086/514209
- By:
- Publication type:
- Article
Theory-Based Analysis of Interest in an HIV Vaccine for Reasons Indicative of Risk Compensation Among African American Women.
- Published in:
- Health Education & Behavior, 2018, v. 45, n. 3, p. 444, doi. 10.1177/1090198117736860
- By:
- Publication type:
- Article
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 7, p. 1750, doi. 10.1002/acn3.52081
- By:
- Publication type:
- Article
Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 10, p. 1643, doi. 10.1002/acn3.51664
- By:
- Publication type:
- Article
Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 1, p. 19, doi. 10.3390/v11010019
- By:
- Publication type:
- Article
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons.
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 6, p. 811, doi. 10.1093/infdis/jis427
- By:
- Publication type:
- Article
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 5, p. 666
- By:
- Publication type:
- Article
Safety and Immunogenicity of Influenza A H5 Subunit Vaccines: Effect of Vaccine Schedule and Antigenic Variant.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. Suppl 2, p. 666
- By:
- Publication type:
- Article
The imperative of influenza vaccines for elderly individuals-an evolving story.
- Published in:
- 2009
- By:
- Publication type:
- commentary
The Imperative of Influenza Vaccines for Elderly Individuals—An Evolving Story.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
Breakthrough Infections during Phase 1 and 2 Prime-Boost HIV-1 Vaccine Trials with Canarypox Vectors (ALVAC) and Booster Dose of Recombinant gp120 or gp160.
- Published in:
- Journal of Infectious Diseases, 2004, v. 190, n. 5, p. 903, doi. 10.1086/423284
- By:
- Publication type:
- Article
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00693-z
- By:
- Publication type:
- Article
Generation of quality-controlled SARS-CoV-2 variant stocks.
- Published in:
- Nature Protocols, 2023, v. 18, n. 12, p. 3821, doi. 10.1038/s41596-023-00897-6
- By:
- Publication type:
- Article
Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?
- Published in:
- Challenge (1077193X), 2007, v. 13, n. 2, p. 61
- By:
- Publication type:
- Article
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
- Published in:
- Nature Immunology, 2014, v. 15, n. 2, p. 195, doi. 10.1038/ni.2789
- By:
- Publication type:
- Article
Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2152, doi. 10.3390/vaccines10122152
- By:
- Publication type:
- Article
The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 663, doi. 10.3390/vaccines8040663
- By:
- Publication type:
- Article
Alterations in the Human Plasma Lipidome in Response to Tularemia Vaccination.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 414, doi. 10.3390/vaccines8030414
- By:
- Publication type:
- Article
Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 413, doi. 10.3390/vaccines8030413
- By:
- Publication type:
- Article
Transcriptomic and Metabolic Responses to a Live-Attenuated Francisella tularensis Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 412, doi. 10.3390/vaccines8030412
- By:
- Publication type:
- Article
Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure.
- Published in:
- Vaccines, 2020, v. 8, n. 3, p. 348, doi. 10.3390/vaccines8030348
- By:
- Publication type:
- Article
Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 69, doi. 10.3390/vaccines8010069
- By:
- Publication type:
- Article
Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 4, doi. 10.3390/vaccines8010004
- By:
- Publication type:
- Article
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine.
- Published in:
- Vaccines, 2020, v. 8, n. 1, p. 126, doi. 10.3390/vaccines8010126
- By:
- Publication type:
- Article
Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.797589
- By:
- Publication type:
- Article
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 4, p. 542, doi. 10.1093/infdis/jiv099
- By:
- Publication type:
- Article
First‐in‐Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID‐19.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 6, p. 1467, doi. 10.1002/cpt.2405
- By:
- Publication type:
- Article
An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Knowledge and Attitudes Toward Covid-19 and Vaccines Among a New York Haredi-Orthodox Jewish Community.
- Published in:
- Journal of Community Health, 2021, v. 46, n. 6, p. 1161, doi. 10.1007/s10900-021-00995-0
- By:
- Publication type:
- Article
Factors Influencing HIV Vaccine Community Engagement in the Urban South.
- Published in:
- Journal of Community Health, 2008, v. 33, n. 4, p. 259, doi. 10.1007/s10900-008-9086-8
- By:
- Publication type:
- Article
Vaccine‐related major cutaneous reaction size correlates with cellular‐mediated immune responses after tularaemia immunisation.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 1, p. 1, doi. 10.1002/cti2.1239
- By:
- Publication type:
- Article
Occupational Exposure to the Ugandan Research Strain (MR766) of Zika Virus.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 10, p. N.PAG, doi. 10.1093/ofid/ofz420
- By:
- Publication type:
- Article